The expression profile and prognostic significance of metallothionein genes in colorectal cancer

Kuo Chen Hung, Tsui Chin Huang, Chia Hsiung Cheng, Ya Wen Cheng, Ding Yen Lin, Jhen Jia Fan, Kuen Haur Lee

Research output: Contribution to journalArticle

Abstract

Colorectal cancer (CRC) is a heterogeneous disease resulting from the combined influence of many genetic factors. This complexity has caused the molecular characterization of CRC to remain uncharacterized, with a lack of clear gene markers associated with CRC and the prognosis of this disease. Thus, highly sensitive tumor markers for the detection of CRC are the most essential determinants of survival. In this study, we examined the simultaneous downregulation of the mRNA levels of six metallothionein (MT) genes in CRC cell lines and public CRC datasets for the first time. In addition, we detected downregulation of these six MT mRNAs’ levels in 30 pairs of tumor (T) and adjacent non-tumor (N) CRC specimens. In order to understand the potential prognostic relevance of these six MT genes and CRC, we presented a four-gene signature to evaluate the prognosis of CRC patients. Further discovery suggested that the four-gene signature (MT1F, MT1G, MT1L, and MT1X) predicted survival better than any combination of two-, three-, four-, five-, or six-gene models. In conclusion, this study is the first to report that simultaneous downregulation of six MT mRNAs’ levels in CRC patients, and their aberrant expression together, accurately predicted CRC patients’ outcomes.

Original languageEnglish
Article number3849
JournalInternational Journal of Molecular Sciences
Volume20
Issue number16
DOIs
Publication statusPublished - Aug 2 2019

Fingerprint

Metallothionein
genes
Colorectal Neoplasms
Genes
cancer
profiles
Messenger RNA
Down-Regulation
prognosis
Tumor Biomarkers
markers
Tumors
tumors
signatures
Cells
Survival
cultured cells
determinants
Cell Line

Keywords

  • Colorectal cancer
  • Gene signature
  • Metallothionein
  • Prognosis

ASJC Scopus subject areas

  • Catalysis
  • Molecular Biology
  • Spectroscopy
  • Computer Science Applications
  • Physical and Theoretical Chemistry
  • Organic Chemistry
  • Inorganic Chemistry

Cite this

The expression profile and prognostic significance of metallothionein genes in colorectal cancer. / Hung, Kuo Chen; Huang, Tsui Chin; Cheng, Chia Hsiung; Cheng, Ya Wen; Lin, Ding Yen; Fan, Jhen Jia; Lee, Kuen Haur.

In: International Journal of Molecular Sciences, Vol. 20, No. 16, 3849, 02.08.2019.

Research output: Contribution to journalArticle

@article{296ada532d6949138ab43e4fd400cc6d,
title = "The expression profile and prognostic significance of metallothionein genes in colorectal cancer",
abstract = "Colorectal cancer (CRC) is a heterogeneous disease resulting from the combined influence of many genetic factors. This complexity has caused the molecular characterization of CRC to remain uncharacterized, with a lack of clear gene markers associated with CRC and the prognosis of this disease. Thus, highly sensitive tumor markers for the detection of CRC are the most essential determinants of survival. In this study, we examined the simultaneous downregulation of the mRNA levels of six metallothionein (MT) genes in CRC cell lines and public CRC datasets for the first time. In addition, we detected downregulation of these six MT mRNAs’ levels in 30 pairs of tumor (T) and adjacent non-tumor (N) CRC specimens. In order to understand the potential prognostic relevance of these six MT genes and CRC, we presented a four-gene signature to evaluate the prognosis of CRC patients. Further discovery suggested that the four-gene signature (MT1F, MT1G, MT1L, and MT1X) predicted survival better than any combination of two-, three-, four-, five-, or six-gene models. In conclusion, this study is the first to report that simultaneous downregulation of six MT mRNAs’ levels in CRC patients, and their aberrant expression together, accurately predicted CRC patients’ outcomes.",
keywords = "Colorectal cancer, Gene signature, Metallothionein, Prognosis",
author = "Hung, {Kuo Chen} and Huang, {Tsui Chin} and Cheng, {Chia Hsiung} and Cheng, {Ya Wen} and Lin, {Ding Yen} and Fan, {Jhen Jia} and Lee, {Kuen Haur}",
year = "2019",
month = "8",
day = "2",
doi = "10.3390/ijms20163849",
language = "English",
volume = "20",
journal = "International Journal of Molecular Sciences",
issn = "1661-6596",
publisher = "MDPI AG",
number = "16",

}

TY - JOUR

T1 - The expression profile and prognostic significance of metallothionein genes in colorectal cancer

AU - Hung, Kuo Chen

AU - Huang, Tsui Chin

AU - Cheng, Chia Hsiung

AU - Cheng, Ya Wen

AU - Lin, Ding Yen

AU - Fan, Jhen Jia

AU - Lee, Kuen Haur

PY - 2019/8/2

Y1 - 2019/8/2

N2 - Colorectal cancer (CRC) is a heterogeneous disease resulting from the combined influence of many genetic factors. This complexity has caused the molecular characterization of CRC to remain uncharacterized, with a lack of clear gene markers associated with CRC and the prognosis of this disease. Thus, highly sensitive tumor markers for the detection of CRC are the most essential determinants of survival. In this study, we examined the simultaneous downregulation of the mRNA levels of six metallothionein (MT) genes in CRC cell lines and public CRC datasets for the first time. In addition, we detected downregulation of these six MT mRNAs’ levels in 30 pairs of tumor (T) and adjacent non-tumor (N) CRC specimens. In order to understand the potential prognostic relevance of these six MT genes and CRC, we presented a four-gene signature to evaluate the prognosis of CRC patients. Further discovery suggested that the four-gene signature (MT1F, MT1G, MT1L, and MT1X) predicted survival better than any combination of two-, three-, four-, five-, or six-gene models. In conclusion, this study is the first to report that simultaneous downregulation of six MT mRNAs’ levels in CRC patients, and their aberrant expression together, accurately predicted CRC patients’ outcomes.

AB - Colorectal cancer (CRC) is a heterogeneous disease resulting from the combined influence of many genetic factors. This complexity has caused the molecular characterization of CRC to remain uncharacterized, with a lack of clear gene markers associated with CRC and the prognosis of this disease. Thus, highly sensitive tumor markers for the detection of CRC are the most essential determinants of survival. In this study, we examined the simultaneous downregulation of the mRNA levels of six metallothionein (MT) genes in CRC cell lines and public CRC datasets for the first time. In addition, we detected downregulation of these six MT mRNAs’ levels in 30 pairs of tumor (T) and adjacent non-tumor (N) CRC specimens. In order to understand the potential prognostic relevance of these six MT genes and CRC, we presented a four-gene signature to evaluate the prognosis of CRC patients. Further discovery suggested that the four-gene signature (MT1F, MT1G, MT1L, and MT1X) predicted survival better than any combination of two-, three-, four-, five-, or six-gene models. In conclusion, this study is the first to report that simultaneous downregulation of six MT mRNAs’ levels in CRC patients, and their aberrant expression together, accurately predicted CRC patients’ outcomes.

KW - Colorectal cancer

KW - Gene signature

KW - Metallothionein

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=85071281698&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071281698&partnerID=8YFLogxK

U2 - 10.3390/ijms20163849

DO - 10.3390/ijms20163849

M3 - Article

C2 - 31394742

AN - SCOPUS:85071281698

VL - 20

JO - International Journal of Molecular Sciences

JF - International Journal of Molecular Sciences

SN - 1661-6596

IS - 16

M1 - 3849

ER -